Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05909904
PHASE2

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

Sponsor: BeiGene

View on ClinicalTrials.gov

Summary

This study is designed to evaluate the efficacy and safety of tislelizumab and tislelizumab in combination with investigational agent(s) in first-line recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Official title: A Randomized, Phase 2, Open-Label, Multi-Arm Study of Tislelizumab in Combination With Investigational Agents as First-Line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2023-07-21

Completion Date

2026-05-28

Last Updated

2025-10-07

Healthy Volunteers

No

Interventions

DRUG

Tislelizumab

Administered intravenously

DRUG

BGB-A425

Administered intravenously

DRUG

LBL-007

Administered intravenously

Locations (73)

Valkyrie Clinical Trials

Los Angeles, California, United States

Stanford Medicine

Stanford, California, United States

Rocky Mountain Cancer Centers, Llp(Us Oncology Research)

Lone Tree, Colorado, United States

Florida Cancer Specialist Research Institute Lake Nona

Orlando, Florida, United States

Florida Cancer Specialist Research Institute Panhandle

Tallahassee, Florida, United States

University of Kentucky Markey Cancer Center

Lexington, Kentucky, United States

Oncology and Hematology Associates of Southwest Virginia, Inc (Us Oncology Research)

Blacksburg, Virginia, United States

Cancer Care Northwest

Spokane Valley, Washington, United States

Northwest Cancer Specialist, Pc(Us Oncology Research)

Vancouver, Washington, United States

Nepean Hospital

Kingswood, New South Wales, Australia

North Shore Private Hospital

St Leonards, New South Wales, Australia

Gold Coast Private Hospital

Gold Coast, Queensland, Australia

Greenslopes Private Hospital

Greenslopes, Queensland, Australia

Cancer Research South Australia

Adelaide, South Australia, Australia

Northeast Health Wangaratta

Wangaratta, Victoria, Australia

St John of God, Murdoch

Murdoch, Western Australia, Australia

British Columbia Cancer Agency the Vancouver Centre

Vancouver, British Columbia, Canada

The Ottawa Hospital Cancer Centre

Ottawa, Ontario, Canada

Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital

Hefei, Anhui, China

Beijing Tongren Hospital, Cmu

Beijing, Beijing Municipality, China

Beijing Cancer Hospital

Beijing, Beijing Municipality, China

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Fujian Cancer Hospital

Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen University

Xiamen, Fujian, China

Sun Yat Sen University Cancer Center

Guangzhou, Guangdong, China

The Tumor Hospital Affiliated to Guangxi Medical University

Nanning, Guangxi, China

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology

Wuhan, Hubei, China

Xiangya Hospital of Central South University

Changsha, Hunan, China

The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

Hunan Cancer Hospital

Changsha, Hunan, China

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University Branch Donghu

Nanchang, Jiangxi, China

The First Hospital of Jilin University

Changchun, Jilin, China

Shandong Cancer Hospital

Jinan, Shandong, China

Shanghai East Hospital

Shanghai, Shanghai Municipality, China

Sichuan Cancer Hospital and Institute

Chengdu, Sichuan, China

West China Hospital, Sichuan University

Chengdu, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China

The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital

Hangzhou, Zhejiang, China

Centre Antoine Lacassagne

Nice, France

Institut Curie Paris

Paris, France

Ico Site Rene Gauducheau

SaintHerblain, France

Institut Gustave Roussy

Villejuif, France

Arensia Exploratory Medicine Llc

Tbilisi, Georgia

Fondazione Irccs Istituto Nazionale Dei Tumori

Milan, Italy

Istituto Europeo Di Oncologia

Milan, Italy

Scientific Institute of Pavia Maugeri

Pavia, Italy

Istituto Clinico Humanitas

Rozzano, Italy

National Cancer Centre Singapore

Singapore, Singapore

Keimyung University Dongsan Hospital

Dalseogu, Daegu Gwang'yeogsi, South Korea

National Cancer Center

Goyang-si, Gyeonggi-do, South Korea

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Seoul National University Hospital

Seoul, Seoul Teugbyeolsi, South Korea

Severance Hospital Yonsei University Health System

Seoul, Seoul Teugbyeolsi, South Korea

Asan Medical Center

Seoul, Seoul Teugbyeolsi, South Korea

Samsung Medical Center

Seoul, Seoul Teugbyeolsi, South Korea

Ico Lhospitalet Hospital Duran I Reynals

Barcelona, Spain

Hospital Clinico San Carlos

Madrid, Spain

Hospital Universitario Virgen Del Rocio

Seville, Spain

Hospital Universitario Miguel Servet

Zaragoza, Spain

Changhua Christian Hospital

Changhua, Taiwan

China Medical University Hospital

Taichung, Taiwan

National Cheng Kung University Hospital

Tainan, Taiwan

Taipei Veterans General Hospital

Taipei, Taiwan

Ramathibodi Hospital Mahidol University

Bangkok, Thailand

Siriraj Hospital

Bangkok, Thailand

Songklanagarind Hospital (Prince of Songkhla University)

Hat Yai, Thailand

Srinagarind Hospital (Khon Kaen University)

Muang, Thailand

Tr Trakya University Health Research and Application Center (Hospital)

Edirne, Turkey (Türkiye)

Medical Park Izmir Hospital

Izmir, Turkey (Türkiye)

Royal Marsden Hospital

London, United Kingdom

Royal Marsden Hospital Sutton

Sutton, United Kingdom